TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Arthro Therapeutics AB
Closing information (x1000 EUR)
Closing information | 2023/12 (consolidated) | 2022/12 | 2021/12 |
Turnover |
19,468
|
3,852
|
15,692 |
Financial expenses |
1,087
|
959
|
23 |
Earnings before taxes |
-6,737
|
-11,769
|
-3,075 |
EBITDA |
-1,674
|
-7,801
|
-904 |
Total assets |
17,273
|
25,762
|
25,156 |
Current assets |
5,124
|
8,278
|
7,432 |
Current liabilities |
6,144
|
2,381
|
5,218 |
Equity capital |
-9,442
|
5,454
|
18,740 |
- share capital |
44
|
33
|
34 |
Employees (average) |
157
|
85
|
80 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 | 2021/12 |
Solvency |
-54.7%
|
21.2%
|
74.5% |
Turnover per employee |
124
|
45
|
196 |
Profit as a percentage of turnover |
-34.6%
|
-305.5%
|
-19.6% |
Return on assets (ROA) |
-32.7%
|
-42.0%
|
-12.1% |
Current ratio |
83.4%
|
347.7%
|
142.4% |
Return on equity (ROE) |
71.4%
|
-215.8%
|
-16.4% |
Change turnover | |||
Change turnover % |
-73%
|
157% | |
Chg. No. of employees | |||
Chg. No. of employees % |
6%
|
74% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.